Biological Information
Background Information:
CP 55,940 is a synthetic cannabinoid molecule developed by Pfizer that has similar but more potent effects to THC in behavioral and receptor binding tests. It is a cannabinoid receptor agonist, with EC50=0.2 and 0.3nM for CB1 and CB2 respectively. Is reported as both an agonist (EC50 = 5nM) and antagonist for GRP55 depending on the assay and dosages uses. Currently used to study the endocannabinoid system. Provided as 5 mg of dry powder.
Usage
Product Type:
Control Ligands & Inhibitors
Application:
Drug Discovery & Development
Storage Conditions:
Store at -20°C. Please avoid multiple freeze/thaw cycles.
Usage disclaimer:
These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Additional Information
Brand:
Eurofins DiscoverX®